Gastricel-I |
18/05/2018 |
CIDEM |
CIMAvax-EGF®-post-COVID19 convalescent with respiratory disorders-adults-Phase II (CORVAXCIM) |
18/06/2021 |
CIM |
ior®EPOCIM in post-COVID-19 convalescent patients with cardiovascular, renal and/or respiratory disorders |
18/06/2021 |
CIM |
SOBERANA - INTERVENTION |
19/03/2021 |
FINLAY |
To evaluate the immunogenicity and safety of SOBERANA® 02 and SOBERANA® Plus as booster of immunity against the omicrom variant of SARS-CoV-2, in adult subjects |
19/05/2023 |
FINLAY |
NeuroEPO-Ataxia-Adults-Phase III |
19/11/2020 |
CIM |
Jusvinza in rheumatoid arthritis |
20/04/2022 |
CIGB |
NeuroEPO in mild-moderate Alzheimer's disease |
20/09/2022 |
CIM |
CIMAvax-EGF/Lung cancer/Biomarkers/Prospective CT |
20/10/2021 |
CIM |
Enhanced recovery protocols in cardiac surgery protocols |
20/11/2019 |
HHA |
Clinical evaluation of the effect anti-inflammatory of the extract of Mangifera indica L. (Vimang®) in patients with diagnosis of Bronchial Asthma |
2009-03-13 |
CQF |
Cicatrix Cream in cutaneous striae |
2009-10-23 |
CATALYSIS |
Cicatrix Cream in post surgical scarps and epidermic burn |
2009-10-23 |
CATALYSIS |
Efficacy of the Glicigen – Viusid in the treatment of external genitals anus wart in children |
2010-09-04 |
CATALYSIS |
Dermosep-I |
2010-12-20 |
CIGB |
EPANEM-III |
2010-12-20 |
CIGB |
188Re-marked Ior C5 MAb in persistent or relapsing ovary epithelial cancer, phase I. |
2010-12-27 |
CIM |
CENTAURO Study |
2011-04-29 |
CIGB |
SOFIA Study |
2011-05-24 |
CIGB |
INJURE Study |
2011-07-11 |
CIGB |